Vivozon -Model VVZ-2471 -Treating Chronic Pain Including Neuropathic Pain

On July 29, 2020, Vivozon applied for a patent for a second pipeline, VVZ-2471, and is currently conducting non-clinical toxicity studies. VVZ-2471 is a new drug candidate for treating chronic pain including neuropathic pain. Recently, the prevention and treatment potential of drug (morphine) addiction, anxiety, and depression have also been demonstrated through non-clinical studies. Upon completion of non-clinical trials for VVZ-2471, Vivozon plans to embark on clinical trials as soon as possible.